Home » Topics » Regulatory

Regulatory
RSS

Xoma claims rBPI21 + antibiotic combination for Gram-negative infections

July 26, 1996

Pimilprost shows wound healing properties in preclinical studies

July 26, 1996

Ulinastatin claimed by Mochida as skin disorder treatment

July 26, 1996

SEPA-ibuprofen formulation fares well in phase II trial

July 26, 1996

Harvard Scientific's liposomal prostaglandin E1 begins clinical trials

July 19, 1996

Alferon N injection undergoes phase III in HCV

July 19, 1996

SmithKline Beecham's new Havrix formulation receives Canadian approval

July 19, 1996

Trial results described for methylphenidate in head injury patients

July 19, 1996

Athena Neurosciences acquires worldwide rights to new formulation of Carbatrol

July 19, 1996

Pharmos receives grant to develop loteprednol/tobramycin combination product

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.